Showing results (31-40 of 93) with videos related to
Sort By:
Pageof 10
Chest|March 16, 2006
Etiology-specific endothelin-1 clearance in human precapillary pulmonary hypertensionDavid Langleben, Jocelyn Dupuis, Isaac Langleben, et al.Pulmonary Circulation|March 13, 2014
Anatomical considerations for the development of a new transcatheter aortopulmonary shunt device in patients with severe pulmonary arterial hypertensionKenneth Guo, David Langleben, Jonathan Afilalo, et al.Pulmonary Circulation|June 10, 2017
Right ventricular ST-elevation myocardial infarction as a cause of death in idiopathic pulmonary arterial hypertensionYang Zhan, Barry Burstein, Ali O Abualsaud, et al.Circulation Research|July 22, 2015
Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial Hypertension: The PHACeT TrialJohn Granton, David Langleben, Michael B Kutryk, et al.The European Respiratory Journal|August 29, 2024
Management of pulmonary hypertension in special conditionsIoana R Preston, Luke S Howard, David Langleben, et al.International Journal of Molecular Sciences|August 10, 2024
Effects of Modulating BMP9, BMPR2, and AQP1 on BMP Signaling in Human Pulmonary Microvascular Endothelial CellsNikolaos S Lotsios, Chrysi Keskinidou, Ioanna Dimopoulou, et al.Journal of the American College of Cardiology|May 16, 2006
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentanRobyn J Barst, David Langleben, David Badesch, et al.Respiratory Medicine|November 27, 2016
Rationale and study design of RESPITE: An open-label, phase 3b study of riociguat in patients with pulmonary arterial hypertension who demonstrate an insufficient response to treatment with phosphodiesterase-5 inhibitorsMarius M Hoeper, James R Klinger, Raymond L Benza, et al.International Journal of Cardiology|December 1, 2019
Impact of saline loading at cardiac catheterization on the classification and management of patients evaluated for pulmonary hypertensionNima Moghaddam, John R Swiston, Jason Weatherald, et al.Vascular Pharmacology|January 2, 2007
Vascular endothelium summary statement V: Pulmonary hypertension and acute lung injury: public health implicationsW Craig Hooper, George A Mensah, S G Haworth, et al.Pageof 10